Dynamk Capital

New York, United States
Investment in life sciences innovation is facilitated by Dynamk Capital.

About Dynamk Capital

Dynamk Capital is a Financial Services company based in New York (United States). Investment in life sciences innovation is facilitated by Dynamk Capital. It operates on a Commission-Based model. Dynamk Capital offers products and services including Life Sciences Fund. Its focus areas include Finance, Investment Management and Venture Capital.

Company details

Investment in the future of life sciences is driven by Dynamk Capital. Focus is placed on supporting entrepreneurs and investors in this sector. Partnerships and funding are provided to companies developing innovative solutions in clinical applications, cell therapies, 3D pathology, and drug discovery. Collaboration with portfolio companies like ZEISS, Alpenglow Biosciences, and Xcell Biosciences is emphasized to advance next-generation technologies and therapies.

  • Headquarters New York, United States
  • Sectors
    Financial Services
  • Website dynamk.vc
  • Social LinkedIn X

Products & Services of Dynamk Capital

Dynamk Capital offers a comprehensive portfolio of products and services, including Life Sciences Fund.

Life Sciences Fund
Investment Fund

Investment in life sciences innovation is provided by fund.

People of Dynamk Capital

3 people are tracked at Dynamk Capital (2 in leadership, 1 in team).

NameRoleGroup
Reinhard Vogt
Venture PartnerLeadership
Daniella Kranjac
Founding Partner, Managing DirectorLeadership
Sebastien Latapie
PrincipalTeam
Premium access

Complete people profiles for Dynamk Capital

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Top companies in Venture Capital Funds

3 companies that operate in the same segment as Dynamk Capital (Venture Capital Funds) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Venture capital firm investing in early-stage tech startups
1972Menlo Park, California, United States
Venture capital investments and support for entrepreneurs in technology and innovation sectors.
1911Redwood City, California, United StatesUSD 691.23 K
Accel is recognized as a leading venture capital firm.
1983Palo Alto, California, United States
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Dynamk Capital

Dynamk Capital is headquartered in New York, United States. It is registered at New York, New York, United States.

Investment in the future of life sciences is driven by Dynamk Capital. Focus is placed on supporting entrepreneurs and investors in this sector. Partnerships and funding are provided to companies developing innovative solutions in clinical applications, cell therapies, 3D pathology, and drug discovery. Collaboration with portfolio companies like ZEISS, Alpenglow Biosciences, and Xcell Biosciences is emphasized to advance next-generation technologies and therapies.

Dynamk Capital offers Life Sciences Fund.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available